101.49
-1.21(-1.18%)
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
867
First IPO Date
January 23, 2020
| Name | Title | Pay | Year Born |
| Mr. Jisheng Wu | Director & Deputy GM | 0 | 1965 |
| Ms. Huiping Lu | Executive Vice President & Director | 0 | 1967 |
| Mr. Binhua Lyu | Deputy GM, EVice President of Chemistry & Director | 0 | 1979 |
| Ms. Zeqi Sheng | Chief Scientific Officer | 0 | 1964 |
| Ms. Qingping Gao | Deputy GM & Board Secretary | 0 | 1977 |
| Shice Shao | Accounting Supervisor | 0 | N/A |
| Mr. Zelin Sheng | Chairman of the Board & GM | 0 | 1960 |
| Mr. Gang Huang | Chief Financial Officer & Deputy GM | 0 | 1971 |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers small molecule and recombinant protein drugs for the treatment of liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, nasopharyngeal carcinomas, myelofibrosis, hemorrhage, and hepatobiliary diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China.